Translation of survival benefits observed in glioblastoma clinical trials to populations and to
longer-term survival remains uncertain. We aimed to assess if≥ 2-year survival has …

Target population These recommendations apply to adult patients diagnosed with newly
diagnosed glioblastoma. Question 1 In adult patients (aged 65 and under) with newly …

The advancements in basic sciences and the availability of sophisticated technological aids
to surgical removal of gliomas have led over the last few years to the rise of innovative …

We reviewed the outcomes of glioma patients enrolled in a prospective observational
registry study of proton beam therapy (PBT) in Japan. The inclusion criteria were glioma …

Introduction Chromosomes 1p/19q co-deletion is a robust molecular marker for the
diagnosis of oligodendroglial tumors, and has been included in the 2016 WHO modified …

Background. Primary intramedullary spinal cord lymphoma (PISCL) is a rare diagnosis with
poorly understood disease progression. Clarification of the factors associated with survival …

Radiation therapy is a standard treatment for brain tumor patients. However, it comes with
side effects, such as neurological deficits. While likely multi-factorial, the effect may in part be …

Objective Oligodendroglioma is a rare primary malignant brain tumor that has highly
variable clinical outcomes. The aim of this study was to investigate demographics …

Introduction Oligodendrogliomas (OGs) account for< 20% of all intracranial tumors and 25%
of gliomas. Despite improvements in imaging techniques allowing for earlier diagnosis, OG …

We evaluated characteristics and different prognostic factors for survival in age-stratified
high-grade glioma in a US cohort. Eligible patients were identified in the Surveillance …